Wells Fargo’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Wells Fargo’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	-$29	–	7715
2020 Q4	$0	Hold	1	–	–	﹤0.01%	7351
2020 Q3	$0	Buy	+1	New	+$23	﹤0.01%	7241
2018 Q4	–	Sell	-1,500	Closed	-$38K	–	6724
2018 Q3	$38K	Buy	+1,500	New	+$38.1K	﹤0.01%	5682

Other funds holding LDRS

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo's LDRS Position: Q1 2021 in Review

Wells Fargo sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q1 2021, closing a stake of 1 share — an estimated $29 sold.

Wells Fargo first reported a position in LDRS in Q3 2018 and held it in 3 quarters. The position peaked at $38K in Q3 2018. 4 funds tracked by Wall St. Rank hold LDRS as of Q1 2021.

Wells Fargo reported no remaining Innovator IBD ETF Leaders ETF position as of Q1 2021 after selling out during the quarter.
Wells Fargo sold 1 Innovator IBD ETF Leaders ETF share in Q1 2021, an estimated $29.
Wells Fargo first reported a position in Innovator IBD ETF Leaders ETF in Q3 2018 and held it in 3 quarters.
Wells Fargo's Innovator IBD ETF Leaders ETF position peaked at $38K in Q3 2018.
4 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q1 2021.

Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.